Income from Continuous Operations: A company's total income or loss before discontinued operations, extraordinary items, preferred stock dividends and accounting change.
Bone Biologics Corp. (BBLG) had Income from Continuous Operations of $-1.02M for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
-- |
|
$-1.02M |
|
-- |
|
-- |
|
$1.04M |
|
$-1.04M |
|
$0.02M |
|
$-1.02M |
|
$-1.02M |
|
$-1.02M |
|
|
Income from Continuous Operations |
$-1.02M |
$-1.02M |
|
$-1.02M |
|
$-1.04M |
|
$-1.04M |
|
0.53M |
|
0.53M |
|
$-1.92 |
|
$-1.92 |
|
| Balance Sheet Financials | |
$3.16M |
|
-- |
|
-- |
|
$3.16M |
|
$0.25M |
|
-- |
|
-- |
|
$0.25M |
|
$2.91M |
|
$2.91M |
|
$2.91M |
|
0.55M |
|
| Cash Flow Statement Financials | |
$-0.93M |
|
-- |
|
$0.35M |
|
$3.33M |
|
$2.75M |
|
$-0.58M |
|
$0.05M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
12.59 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-0.93M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-34.94% |
|
-34.94% |
|
-32.17% |
|
-34.94% |
|
$5.34 |
|
$-1.75 |
|
$-1.75 |
|